by Team Small News | Sep 4, 2025 | Natco, Pharma
A patent battle is unfolding in India between Danish pharmaceutical company Novo Nordisk and Indian pharmaceutical companies, particularly Hyderabad-based Natco Pharma. The dispute centers around Novo Nordisk’s blockbuster weight-loss drug, semaglutide, which is... by Team Small News | Aug 23, 2025 | Natco, Pharma
Natco Pharma, an Indian pharmaceutical company, has filed a lawsuit against Novo Nordisk, a Danish multinational pharmaceutical company, in a Delhi court over intellectual property rights related to semaglutide. Semaglutide is a medication used to treat type 2... by Team Small News | Aug 2, 2025 | Natco, Pharma
Natco Pharma, a leading pharmaceutical company, has announced the appointment of TC Mallikarjun as Vice President – Quality Control (QC) at its Kothur Pharma Division. This appointment is a significant development for the company, as it continues to strengthen... by Team Small News | Jun 27, 2025 | Natco, Pharma
NATCO Pharma, a leading pharmaceutical company based in Hyderabad, India, has received a positive outcome from a recent US Food and Drug Administration (US FDA) audit. The company’s plant, located in Hyderabad, was inspected by the US FDA, and the audit resulted... by Team Small News | May 30, 2025 | Natco, Pharma
Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company’s...
by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus
The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...